Advertisement

Topics

Valeant narrows loss, expects to cut debt

10:20 EDT 8 Aug 2017 | Fox Business

Valeant Pharmaceuticals International Inc. (VRX) on Tuesday reported a loss of $38 million in its second quarter.

Original Article: Valeant narrows loss, expects to cut debt

NEXT ARTICLE

More From BioPortfolio on "Valeant narrows loss, expects to cut debt"

Quick Search
Advertisement